According to a report from the Arkansas Department of Finance and Administration (DFA), the state's medical cannabis sales have hit $200 million in 2022, with patients spending $23.9 million at 38 licensed dispensaries in September, to obtain 4,571 pounds of cannabis, reported KNWA.
“Patients spent approximately $800,000 daily in September on medical marijuana purchases,” said Scott Hardin, a spokesperson for the DFA. “Additionally, 4,571 pounds is the largest month for sales in 2022. Through the first nine months of 2022, patients have spent $205 million to obtain 36,600 pounds of medical marijuana. We anticipate 2022 sales will surpass the $264.9 million spent in 2021,” added Hardin.
Economic impact
There are 92,035 patients already enrolled in the medical cannabis program.
The legalization of recreational marijuana by adults is Issue 4 on the Arkansas general election ballot. If Arkansas voters approve the initiative this November, the market could see more than $460 million in tax revenue over five years. According to the Arkansas Economic Development Institute (AEDI), the legalization of adult-use cannabis would create 6,400 jobs by 2027.
“The measurable economic impact of introducing an adult-use marijuana market, including economic activity diverted from illicit markets, is estimated to increase state gross domestic product by up to $2.36 billion over five years,” said Michael Pakko, chief economist at AEDI.
The five-year analysis found that Arkansas could see yearly sales reach $984 million by 2027 and $163.1 million in revenue from the standard state sales tax on marijuana purchases.
Supplemental revenue would be distributed as follows: $45.5 million in annual stipends for law enforcement, $34 million for the University of Arkansas for Medical Sciences, $15.2 million for drug courts in the state and $212.5 million for a general fund.
Photo by Mick Haupt on Unsplash.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.